Pitfalls, prevention, and treatment of hyperuricemia during tumor lysis syndrome in the era of rasburicase (recombinant urate oxidase)

References

• AlkhujaSUlrichH2002Acute renal failure from spontaneous acute tumor lysis syndrome: a case report and reviewRen Fail242273212071597
   PubMed Web of Science ®Google Scholar
• AndreoliSPClarkJHMcGuireWA1986Purine excretion during tumor lysis in children with acute lymphocytic leukemia receiving allopurinol: relationship to acute renal failureJ Pediatr1092928
   Web of Science ®Google Scholar
• AnnemansLMoeremansKLamotteM2003Incidence, medical resource utilisation and costs of hyperuricemia and tumour lysis syndrome in patients with acute leukaemia and non-Hodgkin’s lymphoma in four European countriesLeuk Lymphoma44778312691145
   PubMed Web of Science ®Google Scholar
• BartonJC1989Tumor lysis syndrome in nonhematopoietic neoplasmsCancer64738402472863
   PubMed Web of Science ®Google Scholar
• BayolACapdevielleJMalazziP2002Modification of a reactive cysteine explains differences between rasburicase and Uricozyme, a natural Aspergillus flavus uricaseBiotechnol Appl Biochem36213112149119
   PubMed Web of Science ®Google Scholar
• BedrnaJPJ1929Akuter harnleiterverschluss nach bestrahlung chronischer leukamien mit rontgenstrahlenMed Klin2517001
   Google Scholar
• BrowningLAKruseJA2005Hemolysis and methemoglobinemia secondary to rasburicase administrationAnn Pharmacother391932516204390
   PubMed Web of Science ®Google Scholar
• CairoMSBishopM2004Tumour lysis syndrome: new therapeutic strategies and classificationBr J Haematol12731115384972
   PubMed Web of Science ®Google Scholar
• CammalleriLMalaguarneraM2007Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in goutInt J Med Sci4839317396159
   PubMedGoogle Scholar
• ChesonBDDutcherBS2005Managing malignancy-associated hyperuricemia with rasburicaseJ Support Oncol31172415796443
   PubMedGoogle Scholar
• CoutinhoAKDeOSMPinczowskiH1997Tumor lysis syndrome in a case of chronic lymphocytic leukemia induced by high-dose corticosteroidsAm J Hematol548568980269
   PubMed Web of Science ®Google Scholar
• FeldJMehtaHBurkesRL2000Acute spontaneous tumor lysis syndrome in adenocarcinoma of the lung: a case reportAm J Clin Oncol23491311039510
   PubMed Web of Science ®Google Scholar
• FillerG2001Acute renal failure in children: aetiology and managementPaediatr Drugs37839211735664
   PubMedGoogle Scholar
• FlombaumCD2000Metabolic emergencies in the cancer patientSemin Oncol273223410864220
   PubMed Web of Science ®Google Scholar
• FriedmanTBPolancoGEAppoldJC1985On the loss of uricolytic activity during primate evolution – I. Silencing of urate oxidase in a hominoid ancestorComp Biochem Physiol B8165393928241
   PubMed Web of Science ®Google Scholar
• GoldmanSCHolcenbergJSFinklesteinJZ2001A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysisBlood972998300311342423
   PubMed Web of Science ®Google Scholar
• HabibGSSalibaWR2002Tumor lysis syndrome after hydrocortisone treatment in metastatic melanoma: a case report and review of the literatureAm J Med Sci323155711908861
   PubMed Web of Science ®Google Scholar
• HoldsworthMTNguyenP2003Role of i.v. allopurinol and rasburicase in tumor lysis syndromeAm J Health Syst Pharm60221322 quiz 2223–414619112
   PubMed Web of Science ®Google Scholar
• HsuHHChanYLHuangCC2004Acute spontaneous tumor lysis presenting with hyperuricemic acute renal failure: clinical features and therapeutic approachJ Nephrol1750615151259
   PubMed Web of Science ®Google Scholar
• HsuHHHuangCC2004Acute spontaneous tumor lysis in anaplastic large T-cell lymphoma presenting with hyperuricemic acute renal failureInt J Hematol79485114979478
   PubMed Web of Science ®Google Scholar
• HummelMBuchheidtDReiterS2005Recurrent chemotherapy-induced tumor lysis syndrome TLS. with renal failure in a patient with chronic lymphocytic leukemia – successful treatment and prevention of TLS with low-dose rasburicaseEur J Haematol755182116313266
   PubMed Web of Science ®Google Scholar
• HutchersonDAGammonDCBhattMS2006Reduced-dose rasburicase in the treatment of adults with hyperuricemia associated with malignancyPharmacotherapy26242716466328
   PubMed Web of Science ®Google Scholar
• JasekAMDayHJ1994Acute spontaneous tumor lysis syndromeAm J Hematol472931
   Web of Science ®Google Scholar
• JehaSPuiCH2005Recombinant urate oxidase rasburicase. in the prophylaxis and treatment of tumor lysis syndromeContrib Nephrol147979
   Web of Science ®Google Scholar
• LarosaCMcMullenLBakdashS2007Acute renal failure from xanthine nephropathy during management of acute leukemiaPediatr Nephrol22325
   Web of Science ®Google Scholar
• LeplatoisPLe DouarinBLoisonG1992High-level production of a peroxisomal enzyme: Aspergillus flavus uricase accumulates intracellularly and is active in Saccharomyces cerevisiaeGene1223945
   Web of Science ®Google Scholar
• LimEBennettPBeilbyJ2003Sample preparation in patients receiving uric acid oxidase rasburicase therapyClin Chem494179
   Web of Science ®Google Scholar
• LiuCYSims-McCallumRPSchifferCA2005A single dose of rasburicase is sufficient for the treatment of hyperuricemia in patients receiving chemotherapyLeuk Res2963515541477
   PubMed Web of Science ®Google Scholar
• LocatelliFRossiF2005Incidence and pathogenesis of tumor lysis syndromeContrib Nephrol1471815604602
   PubMed Web of Science ®Google Scholar
• MahmoudHHLevergerGPatteC1998Advances in the management of malignancy-associated hyperuricaemiaBr J Cancer77Suppl 48209647613
   PubMed Web of Science ®Google Scholar
• MaseraGJankovicMZurloMG1982Urate-oxidase prophylaxis of uric acid-induced renal damage in childhood leukemiaJ Pediatr100525
   Web of Science ®Google Scholar
• McDonnellAMLenzKLFrei-LahrDA2006Single-dose rasburicase 6 mg in the management of tumor lysis syndrome in adultsPharmacotherapy268061216716134
   PubMed Web of Science ®Google Scholar
• NavolanicPMPuiCHLarsonRA2003Elitek-rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002Leukemia1749951412646938
   PubMed Web of Science ®Google Scholar
• OldfieldVPerryCM2006Spotlight on rasburicase in anticancer therapy-induced hyperuricemiaBioDrugs20197916724869
   PubMed Web of Science ®Google Scholar
• ParhamWAMehdiradAABiermannKM2006Hyperkalemia revisitedTex Heart Inst J3340716572868
   PubMed Web of Science ®Google Scholar
• PatteCSakirogluCAnsoborloS2002Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Societe Francaise d’Oncologie Pediatrique LMB89 protocolAnn Oncol137899512075750
   PubMed Web of Science ®Google Scholar
• PeaF2005Pharmacology of drugs for hyperuricemia. Mechanisms, kinetics and interactionsContrib Nephrol147354615604604
   PubMed Web of Science ®Google Scholar
• PessionABarbieriE2005Treatment and prevention of tumor lysis syndrome in children. Experience of Associazione Italiana Ematologia Oncologia PediatricaContrib Nephrol147809215604608
   PubMed Web of Science ®Google Scholar
• PuiCH2002Rasburicase: a potent uricolytic agentExpert Opin Pharmacother34334211934348
   PubMedGoogle Scholar
• PuiCHJehaSIrwinD2001aRecombinant urate oxidase rasburicase. in the prevention and treatment of malignancy-associated hyperuricemia in pediatric and adult patients: results of a compassionate-use trialLeukemia151505911587206
   PubMed Web of Science ®Google Scholar
• PuiCHMahmoudHHWileyJM2001bRecombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphomaJ Clin Oncol1969770411157020
   PubMed Web of Science ®Google Scholar
• PuiCHRellingMVLascombesF1997Urate oxidase in prevention and treatment of hyperuricemia associated with lymphoid malignanciesLeukemia11181369369411
   PubMed Web of Science ®Google Scholar
• RibeiroRCPuiCH2003Recombinant urate oxidase for prevention of hyperuricemia and tumor lysis syndrome in lymphoid malignanciesClin Lymphoma32253212672271
   PubMedGoogle Scholar
• RiccioBMatoAOlsonEM2006Spontaneous tumor lysis syndrome in acute myeloid leukemia: two cases and a review of the literatureCancer Biol Ther51614717204864
   PubMed Web of Science ®Google Scholar
• SparanoJRamirezMWiernikPH1990Increasing recognition of corticosteroid-induced tumor lysis syndrome in non-Hodgkin’s lymphomaCancer65107232302658
   PubMed Web of Science ®Google Scholar
• StarkMEDyerMCCoonleyCJ1987Fatal acute tumor lysis syndrome with metastatic breast carcinomaCancer6076243594399
   PubMed Web of Science ®Google Scholar
• TarellaCBonoDZanniM2005Intensive chemotherapy in patients with lymphoma. Management of the risk of hyperuricemiaContrib Nephrol1479310415604609
   PubMed Web of Science ®Google Scholar
• TomlinsonGCSolbergLAJr1984Acute tumor lysis syndrome with metastatic medulloblastoma. A case reportCancer53178356199103
   PubMed Web of Science ®Google Scholar
• TrifilioSGordonLSinghalS2006Reduced-dose rasburicase recombinant xanthine oxidase. in adult cancer patients with hyperuricemiaBone Marrow Transplant37997100116708061
   PubMed Web of Science ®Google Scholar
• Turtureanu-HanganuE2002Emergency care: the tumor lysis syndromeRev Med Chir Soc Med Nat Iasi1067051114974215
   PubMedGoogle Scholar
• UengS2005Rasburicase Elitek.: a novel agent for tumor lysis syndromeProc Bayl Univ Med Cent18275916200184
   PubMedGoogle Scholar
• WossmannWSchrappeMMeyerU2003Incidence of tumor lysis syndrome in children with advanced stage Burkitt’s lymphoma/leukemia before and after introduction of prophylactic use of urate oxidaseAnn Hematol82160512634948
   PubMed Web of Science ®Google Scholar
• YeldandiAVYeldandiVKumarS1991Molecular evolution of the urate oxidase-encoding gene in hominoid primates: nonsense mutationsGene10928141765273
   PubMed Web of Science ®Google Scholar